Determination of a novel integron-located variant (blaOXA-320) of Class D β-lactamase in Proteus mirabilis

Journal of Basic Microbiology

Volumn 54, Issue 10, 2014, Pages 1030-1035

  Cicek, Aysegul Copur ^a   Duzgun, Azer Ozad ^b   Saral, Aysegul ^c   Sandalli, Cemal ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

^c ARTVIN CORUH UNIVERSITY   (Turkey)

Author keywords

blaOXA 320 gene; Class D lactamase; Integron; P. mirabilis

Indexed keywords

BETA LACTAMASE; BETA-LACTAMASE OXA-2; RNA 16S;

CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; INTEGRON; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; PROTEUS MIRABILIS; TURKEY; URINE;

BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTEGRONS; MOLECULAR SEQUENCE DATA; PROTEUS MIRABILIS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TURKEY; URINE;

EID: 84907874559     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.201300264     Document Type: Article

References (33)

1. Jacobsen, S.M., Stickler, D.J., Mobley H.L., Shirtliff, M.E., 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev., 21, 26-59.
2. Chen, C.Y., Chen, Y.H., Lu, P.L., Lin, W.R. et al., 2012. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. J. Microbiol. Immunol. Infect., 45, 228-236.
3. Recchia, G.D., Hall, R.M., 1995. Gene cassettes: a new class of mobile element. Microbiology, 141, 3015-3027.
4. Collis, C.M., Hall, R.M., 1992. Gene cassettes from the insert region of integrons are excised as covalently closed circles. Mol. Microbiol., 6, 2875-2885.
5. Hall, R.M., Brookes, D.E., Stokes, HW., 1991. Site-specific insertion of genes into integrons: role of the 59-base element and determination of the recombination cross-over point. Mol. Microbiol., 5, 1941-1959.
6. Fluit, A.C., Schmitz, F.J., 2004. Resistance integrons and super-integrons. Clin. Microbiol. Infect., 10, 272-288.
7. Goldstein, C., Lee, M.D., Sanchez, S., Hudson, C. et al., 2001. Incidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics. Antimicrob. Agents Chemother., 45, 723-726.
8. Rowe-Magnus, D.A., Guerout, A.M., Mazel, D., 2002. Bacterial resistance evolution by recruitment of super-integron gene cassettes. Mol. Microbiol., 43, 1657-1669.
9. Carattoli, A., 2001. Importance of integrons in the diffusion of resistance. Vet. Res., 32, 243-259.
10. Hansson, K., Sundström, L., Pelletier, A., Roy, P.H., 2002. IntI2 integron integrase in Tn7. J. Bacteriol., 184, 1712-1721.
11. Guo, X., Xia, R., Han, N., Xu, H., 2011. Genetic diversity analyses of class 1 integrons and their associated antimicrobial resistance genes in Enterobacteriaceae strains recovered from aquatic habitats in China. Lett. Appl. Microbiol., 52, 667-675.
12. Bush, K., Fisher, J.F., 2011. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu. Rev. Microbiol., 65, 455-478.
13. Bush, K., Jacoby, G.A., Medeiros, A.A., 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 39, 1211-1233.
14. Clinical and Laboratory Standards Institute, 2013. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing M100-S23 CLSI, Wayne, PA.
15. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. et al., 1990. Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
16. Benson, D.A., Karsch-Mizrachi, I., Clark, K., Lipman, D.J. et al., 2012. GenBank. Nucleic Acids Res., 40 (Database issue), D48-D53.
17. Rice, L.B., Willey, S.H., Papanicolaou, G.A., Medeiros, A.A. et al., 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at Massachusetts chronic care facility. Antimicrob. Agents Chemother., 34, 2193-2199.
18. Bonnet, R., Marchandin, H., Chanal, C., Sirot, D. et al., 2002. Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother., 46, 2004-2006.
19. Pagani, L., Migliavacca, R., Pallecchi, L., Matti, C. et al., 2002. Emerging extended-spectrum beta-lactamases in Proteus mirabilis. J. Clin. Microbiol., 40, 1549-1552.
20. Khan, A.U., Musharraf, A., 2004. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med. Sci. Monit., 10, 598-602.
21. Bialek, W.A., Zajac, E., Parniewski, P., Kaca, W., 2013. Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains. Mol. Biol. Rep., 40, 3429-3435.
22. Walsh, T.R., 2008. Clinically significant carbapenemases: an update. Curr. Opin. Infect. Dis., 21, 367-371.
23. Wright, G.D., 1999. Aminoglycoside-modifying enzymes. Curr. Opin. Microbiol., 2, 499-503.
24. Clark, N.C., Olsvik, Ø., Swenson, J.M., Spiegel, C.A. et al., 1999. Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis. Antimicrob. Agents Chemother., 43, 157-160.
25. Machado, E., Canton, R., Baquero, F., Galan, J.C. et al., 2005. Integron content of extended-spectrum-β-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob. Agents Chemother., 49, 1823-1829.
26. White, P.A., McIver, C.J., Rawlinson, W., 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob. Agents Chemother., 45, 2658-2661.
27. Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Carmeli, Y., 2008. Dissemination of the CTX-M-25 family β-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. J. Antimicrob. Chemother., 62, 289-295.
28. Hussein, A.I., Ahmed, A.M., Sato, M., Shimamoto, T., 2009. Characterization of integrons and antimicrobial resistance genes in clinical isolates of Gram negative bacteria from Palestinian hospitals. Microbiol. Immunol., 53, 595-602.
29. de Toro, M., Sáenz, Y., Cercenado, E., Rojo-Bezares, B. et al., 2011. Genetic characterization of the mechanisms of resistance to amoxicillin/clavulanate and third-generation cephalosporins in Salmonella enterica from three Spanish hospitals. Int. Microbiol., 14, 173-181.
30. Moura, A., Henriques, I., Ribeiro, R., Correia, A., 2007. Prevalence and characterization of integrons from bacteria isolated from a slaughterhouse wastewater treatment plant. J. Antimicrob. Chemother., 60, 1243-1250.
31. Moubareck, C., Brémont, S., Conroy, M.C., Courvalin, P. et al., 2009. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob. Agents Chemother., 58, 3579-3581.
32. Jeon, B.C., Jeong, S.H., Bae, I.K., Bong, K.S. et al., 2005. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol., 43, 2241-2245.
33. Lévesque, C., Piche, L., Larose, C., Roy, P.H., 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother., 39, 185-191.